Enterprise Value to EBITDA Multiple ratio Analysis of Phathom Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-3500.04
Period Ending - Dec-22
Very Poor EV to EBITDA
-1.80
Growth
-194469.57 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-3.65
EV to EBITDA Analysis of Phathom Pharmaceuticals Inc
| EV to EBITDA Ratio of PHAT drastically fell by -194469.57 % this year. |
| EV to EBITDA Ratio with value of 0.453 was highest in Year Dec-19 in last Five Years. |
| EV to EBITDA Ratio of PHAT trending down for at least three Years. |
| Latest EV to EBITDA Ratio with value of -3500.04 is lower than Average EV to EBITDA of -700.69 in last five years. |
Other EV to EBITDA Related Info of PHAT that may interest you.
Phathom Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PHAT | 9.42 | 10.19 | 7.56 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Phathom Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| EV to EBITDA | -3500.04 | -1.80 | -1.47 | -0.584 | 0.453 | -45.90 |
| Change | -194469.57 % | -22.28 % | -151.94 % | -228.82 % | 100.99 % |
FY Chart of Enterprise Value to EBITDA Multiple of Phathom Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)